Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Ann Ig. 2024 Mar-Apr;36(2):215-226. doi: 10.7416/ai.2024.2607. Epub 2024 Jan 31.
Subjects with selected underlying medical conditions are at higher risk of infection and severe outcomes from vaccines preventable diseases. While most countries adopt life-course approaches to vaccination, high-risk group immunization programmes could maximize individual protection, while contributing to population health. The COVID-19 pandemic stimulated the planning and implementation of successful hospital-based high-risk groups' immunization models. However, in Italy, high-risk subjects' vaccine coverage is not actively monitored at the national or regional level, nor shared guidelines exist yet on hospital-based immunization programmes.
The study reports findings from a region-wide assessment of the availability, characteristics, and setting-specific features of hospital-based immunization programmes for high-risk subjects in the Lombardy region.
Fondazione The Bridge a not-for-profit organization based in Milan, in collaboration with the Prevention Unit of the Lombardy Region Directorate for Welfare, and the University of Pavia coordinated a project aimed at bringing together regional health institutions, key stakeholders, academic experts, scientific societies and patients' associations to assess high-risk subjects' barriers to vaccine uptake and inform preventive programmes and policies. In this context, we designed and implemented a survey to systematically map the existence and characteristics of hospital-based immunization programmes targeting high-risk subjects. The survey was proposed to all 115 hospital medical directions of the Lombardy region.
We collected data from 97 hospital medical directions, with a response rate of 85%. Among respondents, 24% were publi-cly managed hospitals, 17% were Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) and 59% accredited private hospitals. Overall, 51.5% facilities in the Lombardy Region reported to actively administer vaccines to high-risk subjects in hospital settings, the prevalence being 89.6% in public hospitals. Among hospitals where vaccines are actively administered, 46% reported to have centralized vaccines ambulatory clinics, while 54% reported to administer vaccines in the context of inpa-tient care, within clinical wards. In 14% of hospitals vaccination counselling is carried out at the hospital level, while patients are referred to community services for the vaccine administration, 58% have established clinical pathways and formalized internal procedures to integrate vaccine prevention within the clinical care.
Half of hospital facilities in the Lombardy Region administer vaccines to high-risk patients. Hospital-based im-munization models vary widely by vaccines programmes, organizational aspects, vaccines procurement and workforce involved. Identifying best practices and effective models can help tackle current challenges and improve immunization coverage for at-risk groups.
某些特定基础医学病症的患者面临更高的感染风险和疫苗可预防疾病的严重后果。虽然大多数国家都采用了终身疫苗接种方法,但高风险群体免疫计划可以最大限度地保护个体,同时也有助于改善人群健康。COVID-19 大流行刺激了成功的基于医院的高风险群体免疫计划的规划和实施。然而,在意大利,国家或地区层面并未积极监测高风险人群的疫苗接种覆盖率,也没有关于基于医院的免疫计划的共享指南。
本研究报告了伦巴第大区基于医院的高风险人群免疫计划的可用性、特征和特定环境特征的区域范围评估结果。
米兰的非营利组织 Fondazione The Bridge 与伦巴第大区福利局预防科以及帕维亚大学合作,协调了一个项目,旨在将区域卫生机构、主要利益攸关方、学术专家、科学协会和患者协会聚集在一起,评估高风险人群疫苗接种障碍,并为预防计划和政策提供信息。在这种情况下,我们设计并实施了一项调查,以系统地绘制针对高风险人群的基于医院的免疫计划的存在和特征。该调查向伦巴第大区的 115 家医院医疗方向提出。
我们从 97 家医院医疗方向收集了数据,响应率为 85%。在受访者中,24%为公立管理医院,17%为科研、住院和医疗保健学会(IRCCS),59%为认证私立医院。总体而言,伦巴第大区 51.5%的医疗机构报告在医院环境中积极为高风险人群接种疫苗,公立医疗机构的流行率为 89.6%。在积极管理疫苗的医院中,46%报告设有集中疫苗门诊,而 54%报告在住院病房内进行疫苗接种。在 14%的医院中,疫苗接种咨询在医院层面进行,而患者则被转介到社区服务机构进行疫苗接种,58%制定了临床路径并正式制定了内部程序,将疫苗预防纳入临床护理。
伦巴第大区一半的医院设施为高风险患者接种疫苗。基于医院的免疫模式因疫苗计划、组织方面、疫苗采购和参与劳动力而有很大差异。确定最佳实践和有效模式有助于解决当前的挑战,并提高高危人群的免疫覆盖率。